Cargando…

Modeling the competition between lung metastases and the immune system using agents

BACKGROUND: The Triplex cell vaccine is a cancer cellular vaccine that can prevent almost completely the mammary tumor onset in HER-2/neu transgenic mice. In a translational perspective, the activity of the Triplex vaccine was also investigated against lung metastases showing that the vaccine is an...

Descripción completa

Detalles Bibliográficos
Autores principales: Pennisi, Marzio, Pappalardo, Francesco, Palladini, Ariannna, Nicoletti, Giordano, Nanni, Patrizia, Lollini, Pier-Luigi, Motta, Santo
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2010
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2957681/
https://www.ncbi.nlm.nih.gov/pubmed/21106120
http://dx.doi.org/10.1186/1471-2105-11-S7-S13
_version_ 1782188248223711232
author Pennisi, Marzio
Pappalardo, Francesco
Palladini, Ariannna
Nicoletti, Giordano
Nanni, Patrizia
Lollini, Pier-Luigi
Motta, Santo
author_facet Pennisi, Marzio
Pappalardo, Francesco
Palladini, Ariannna
Nicoletti, Giordano
Nanni, Patrizia
Lollini, Pier-Luigi
Motta, Santo
author_sort Pennisi, Marzio
collection PubMed
description BACKGROUND: The Triplex cell vaccine is a cancer cellular vaccine that can prevent almost completely the mammary tumor onset in HER-2/neu transgenic mice. In a translational perspective, the activity of the Triplex vaccine was also investigated against lung metastases showing that the vaccine is an effective treatment also for the cure of metastases. A future human application of the Triplex vaccine should take into account several aspects of biological behavior of the involved entities to improve the efficacy of therapeutic treatment and to try to predict, for example, the outcomes of longer experiments in order to move faster towards clinical phase I trials. To help to address this problem, MetastaSim, a hybrid Agent Based - ODE model for the simulation of the vaccine-elicited immune system response against lung metastases in mice is presented. The model is used as in silico wet-lab. As a first application MetastaSim is used to find protocols capable of maximizing the total number of prevented metastases, minimizing the number of vaccine administrations. RESULTS: The model shows that it is possible to obtain "in silico" a 45% reduction in the number of vaccinations. The analysis of the results further suggests that any optimal protocol for preventing lung metastases formation should be composed by an initial massive vaccine dosage followed by few vaccine recalls. CONCLUSIONS: Such a reduction may represent an important result from the point of view of translational medicine to humans, since a downsizing of the number of vaccinations is usually advisable in order to minimize undesirable effects. The suggested vaccination strategy also represents a notable outcome. Even if this strategy is commonly used for many infectious diseases such as tetanus and hepatitis-B, it can be in fact considered as a relevant result in the field of cancer-vaccines immunotherapy. These results can be then used and verified in future "in vivo" experiments, and their outcome can be used to further improve and refine the model.
format Text
id pubmed-2957681
institution National Center for Biotechnology Information
language English
publishDate 2010
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-29576812010-10-21 Modeling the competition between lung metastases and the immune system using agents Pennisi, Marzio Pappalardo, Francesco Palladini, Ariannna Nicoletti, Giordano Nanni, Patrizia Lollini, Pier-Luigi Motta, Santo BMC Bioinformatics Proceedings BACKGROUND: The Triplex cell vaccine is a cancer cellular vaccine that can prevent almost completely the mammary tumor onset in HER-2/neu transgenic mice. In a translational perspective, the activity of the Triplex vaccine was also investigated against lung metastases showing that the vaccine is an effective treatment also for the cure of metastases. A future human application of the Triplex vaccine should take into account several aspects of biological behavior of the involved entities to improve the efficacy of therapeutic treatment and to try to predict, for example, the outcomes of longer experiments in order to move faster towards clinical phase I trials. To help to address this problem, MetastaSim, a hybrid Agent Based - ODE model for the simulation of the vaccine-elicited immune system response against lung metastases in mice is presented. The model is used as in silico wet-lab. As a first application MetastaSim is used to find protocols capable of maximizing the total number of prevented metastases, minimizing the number of vaccine administrations. RESULTS: The model shows that it is possible to obtain "in silico" a 45% reduction in the number of vaccinations. The analysis of the results further suggests that any optimal protocol for preventing lung metastases formation should be composed by an initial massive vaccine dosage followed by few vaccine recalls. CONCLUSIONS: Such a reduction may represent an important result from the point of view of translational medicine to humans, since a downsizing of the number of vaccinations is usually advisable in order to minimize undesirable effects. The suggested vaccination strategy also represents a notable outcome. Even if this strategy is commonly used for many infectious diseases such as tetanus and hepatitis-B, it can be in fact considered as a relevant result in the field of cancer-vaccines immunotherapy. These results can be then used and verified in future "in vivo" experiments, and their outcome can be used to further improve and refine the model. BioMed Central 2010-10-15 /pmc/articles/PMC2957681/ /pubmed/21106120 http://dx.doi.org/10.1186/1471-2105-11-S7-S13 Text en Copyright ©2010 Pennisi et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Proceedings
Pennisi, Marzio
Pappalardo, Francesco
Palladini, Ariannna
Nicoletti, Giordano
Nanni, Patrizia
Lollini, Pier-Luigi
Motta, Santo
Modeling the competition between lung metastases and the immune system using agents
title Modeling the competition between lung metastases and the immune system using agents
title_full Modeling the competition between lung metastases and the immune system using agents
title_fullStr Modeling the competition between lung metastases and the immune system using agents
title_full_unstemmed Modeling the competition between lung metastases and the immune system using agents
title_short Modeling the competition between lung metastases and the immune system using agents
title_sort modeling the competition between lung metastases and the immune system using agents
topic Proceedings
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2957681/
https://www.ncbi.nlm.nih.gov/pubmed/21106120
http://dx.doi.org/10.1186/1471-2105-11-S7-S13
work_keys_str_mv AT pennisimarzio modelingthecompetitionbetweenlungmetastasesandtheimmunesystemusingagents
AT pappalardofrancesco modelingthecompetitionbetweenlungmetastasesandtheimmunesystemusingagents
AT palladiniariannna modelingthecompetitionbetweenlungmetastasesandtheimmunesystemusingagents
AT nicolettigiordano modelingthecompetitionbetweenlungmetastasesandtheimmunesystemusingagents
AT nannipatrizia modelingthecompetitionbetweenlungmetastasesandtheimmunesystemusingagents
AT lollinipierluigi modelingthecompetitionbetweenlungmetastasesandtheimmunesystemusingagents
AT mottasanto modelingthecompetitionbetweenlungmetastasesandtheimmunesystemusingagents